Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase 1, Single-Dose PK and Safety Study with NI-03 followed by a Phase 2, Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of NI-03 Compared to Placebo in Subjects with Chronic Pancreatitis (IRB 228465)


Collapse Overview 
Collapse sponsor award id
NI03


Collapse Biography 

Collapse Time 
Collapse start date
2018-12-11